AzTrials
AzTrials

Flexible UreteroscopyNCT05857501

Preoperative Prediction of Flexible Ureteroscopy Outcome in the Treatment of Renal Calculi

An observational study of Flexible Ureteroscopy, run by Menoufia University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To predict the outcome of flexible ureteroscopy in the management of renal stones based on preoperative scoring module using five preoperative parameters that have effect on stone free status postoperatively. Read more about this study

Who is it for?
Any age
Conditions the study is for
Flexible Ureteroscopy
What is being tested?
abdominopelvic computerized tomography (CT) without contrast
Type of treatment
Medical device
How many people
72 participants
Where
No sites listed yet
Study dates
10 May 2023to Apr 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients with renal stones that are < 2 cm in maximal diameter will be recruited to the study. Patients will be counseled for flexible ureteroscopy, and the procedure will be explained to them with discussion about its pros and cons. Patients agreeable to enrollment will sign an informed written consent after fulfillment of ethical approval forms.Stone free rate will be assessed at one week, one month, and three months post-operatively using Plain X-ray for radio-opaque stones and NCCT for radiolucent stones. Stone free rate will be determined by no stone fragment > 4mm. Number of ancillary procedures required to reach SF will be reported

Who may be able to join

  • Renal stones (≤ 2 cm)
  • Radiolucent stone resistant to SWL and oral chemical dissolution treatment (≤2cm)

Who cannot join

  • Large stones (> 2 cm).
  • Staghorn stone (stone involving the renal pelvis and more than two calyces).
  • Patient preference of other treatment modality

Trial locations and contacts

No sites are listed yet.

Islam Mohamed Abu-Bakr Mansour, M.B.B.Ch contact

201069121037

islam_mansour@med.menofia.edu.eg

Mohamed Abdelgaber Selim, ASS-PROF contact

201066812765

mohamed.abdelgaber@med.menofia.edu.eg

About this study

To predict the outcome of flexible ureteroscopy in the management of renal stones based on preoperative scoring module using five preoperative parameters that have effect on stone free status postoperatively.

Read the detailed description

Although flexible ureteroscopy has been in use for decades, neither the European Association of Urology (EAU) nor the American Urological association (AUA), in their clinical guidelines, recommends flexible ureteroscopy (FURS) as a first-line procedural treatment for renal stones . Several reports showed that FURS is a suitable alternative to shockwave lithotripsy (SWL) and percutaneous nephrolithotripsy (PCNL) for the treatment of renal stones, with potentially higher stone-free rates than SWL and lower morbidity than PCNL.

Safe and effective removal by FURS of multiple and large intrarenal stones, including lower pole calculi, has been documented suggesting that FURS is effective for complex intrarenal stone removal . With the multitude of available procedures, selection of the optimal one for management of renal stone is becoming more challenging.

Established models for predicting the outcomes of SWL and PCNL exist . However, a predictive model for predicting the outcome of URS is still in development , particularly for FURS treatment of renal stones. Four scores have been developed for FURS. Two of these have been compared and validated in different cohorts: the Resolu Unsal Stone Score (RUSS) and modified Seoul National University Renal Stone Complexity (S-ReSC) score , the other two scores, the S.T.O.N.E score described by Molina et al. and Ito's nomogram.

Many studies have demonstrated that stone volume is the most significant factor predictive of stone-free status (SF) after FURS. The investigators speculate that stone volume combined with other variables might improve prediction of SF after FURS. The aim of the present study is to evaluate various preoperative parameters as predictors of FURS outcome based on the Ito's nomogram

Being tested
abdominopelvic computerized tomography (CT) without contrast

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • abdominopelvic computerized tomography (CT) without contrastDevice

    Also called digital KUB (plain x-ray on urology system )

    scan combines a series of X-ray images taken from different angles around your body and uses computer processing to create cross-sectional images (slices) of the bones, blood vessels and soft tissues inside your body. CT scan images provide more-detailed information than plain X-rays do.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. stone free rate after flexible ureteroscopy

    the investigators predict the outcome of flexible ureteroscopy in the management of renal stones based on preoperative scoring module using five preoperative parameters that have effect on stone free rate postoperatively.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2023
  2. Study start10 May 2023 (estimated)
  3. Primary completionJan 2024 (estimated)
  4. Study completionApr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05857501
Sponsor's protocol ID
FURS outcome prediciton
Status last verified
May 2023
First submitted
10 Apr 2023
Last updated
12 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Preminger GM, Tiselius HG, Assimos DG, Alken P, Buck C, Gallucci M, Knoll T, Lingeman JE, Nakada SY, Pearle MS, Sarica K, Turk C, Wolf JS Jr; EAU/AUA Nephrolithiasis Guideline Panel. 2007 guideline for the management of ureteral calculi. J Urol. 2007 Dec;178(6):2418-34. doi: 10.1016/j.juro.2007.09.107. No abstract available.

    PubMed 17993340
  • Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M; Working Party on Lithiasis, European Association of Urology. Guidelines on urolithiasis. Eur Urol. 2001 Oct;40(4):362-71. doi: 10.1159/000049803.

    PubMed 11713390
  • El-Nahas AR, Ibrahim HM, Youssef RF, Sheir KZ. Flexible ureterorenoscopy versus extracorporeal shock wave lithotripsy for treatment of lower pole stones of 10-20 mm. BJU Int. 2012 Sep;110(6):898-902. doi: 10.1111/j.1464-410X.2012.10961.x. Epub 2012 Feb 28.

    PubMed 22372915
  • Cohen J, Cohen S, Grasso M. Ureteropyeloscopic treatment of large, complex intrarenal and proximal ureteral calculi. BJU Int. 2013 Mar;111(3 Pt B):E127-31. doi: 10.1111/j.1464-410X.2012.11352.x. Epub 2012 Jul 3.

    PubMed 22757752
  • Pearle MS, Lingeman JE, Leveillee R, Kuo R, Preminger GM, Nadler RB, Macaluso J, Monga M, Kumar U, Dushinski J, Albala DM, Wolf JS Jr, Assimos D, Fabrizio M, Munch LC, Nakada SY, Auge B, Honey J, Ogan K, Pattaras J, McDougall EM, Averch TD, Turk T, Pietrow P, Watkins S. Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol. 2008 May;179(5 Suppl):S69-73. doi: 10.1016/j.juro.2008.03.140.

    PubMed 18405758
  • Akman T, Binbay M, Ozgor F, Ugurlu M, Tekinarslan E, Kezer C, Aslan R, Muslumanoglu AY. Comparison of percutaneous nephrolithotomy and retrograde flexible nephrolithotripsy for the management of 2-4 cm stones: a matched-pair analysis. BJU Int. 2012 May;109(9):1384-9. doi: 10.1111/j.1464-410X.2011.10691.x. Epub 2011 Oct 28.

    PubMed 22093679
  • Breda A, Ogunyemi O, Leppert JT, Schulam PG. Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones. Eur Urol. 2009 May;55(5):1190-6. doi: 10.1016/j.eururo.2008.06.019. Epub 2008 Jun 13.

    PubMed 18571315
  • Breda A, Ogunyemi O, Leppert JT, Lam JS, Schulam PG. Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater--is this the new frontier? J Urol. 2008 Mar;179(3):981-4. doi: 10.1016/j.juro.2007.10.083. Epub 2008 Jan 22.

    PubMed 18207179
  • Takazawa R, Kitayama S, Tsujii T. Successful outcome of flexible ureteroscopy with holmium laser lithotripsy for renal stones 2 cm or greater. Int J Urol. 2012 Mar;19(3):264-7. doi: 10.1111/j.1442-2042.2011.02931.x. Epub 2011 Dec 6.

    PubMed 22145599
  • Wiesenthal JD, Ghiculete D, Ray AA, Honey RJ, Pace KT. A clinical nomogram to predict the successful shock wave lithotripsy of renal and ureteral calculi. J Urol. 2011 Aug;186(2):556-62. doi: 10.1016/j.juro.2011.03.109.

    PubMed 21684557
  • Kanao K, Nakashima J, Nakagawa K, Asakura H, Miyajima A, Oya M, Ohigashi T, Murai M. Preoperative nomograms for predicting stone-free rate after extracorporeal shock wave lithotripsy. J Urol. 2006 Oct;176(4 Pt 1):1453-6; discussion 1456-7. doi: 10.1016/j.juro.2006.06.089.

    PubMed 16952658
  • Smith A, Averch TD, Shahrour K, Opondo D, Daels FP, Labate G, Turna B, de la Rosette JJ; CROES PCNL Study Group. A nephrolithometric nomogram to predict treatment success of percutaneous nephrolithotomy. J Urol. 2013 Jul;190(1):149-56. doi: 10.1016/j.juro.2013.01.047. Epub 2013 Jan 23.

    PubMed 23353048
  • Imamura Y, Kawamura K, Sazuka T, Sakamoto S, Imamoto T, Nihei N, Suzuki H, Okano T, Nozumi K, Ichikawa T. Development of a nomogram for predicting the stone-free rate after transurethral ureterolithotripsy using semi-rigid ureteroscope. Int J Urol. 2013 Jun;20(6):616-21. doi: 10.1111/j.1442-2042.2012.03229.x. Epub 2012 Nov 19.

    PubMed 23163835
  • Resorlu B, Unsal A, Gulec H, Oztuna D. A new scoring system for predicting stone-free rate after retrograde intrarenal surgery: the "resorlu-unsal stone score". Urology. 2012 Sep;80(3):512-8. doi: 10.1016/j.urology.2012.02.072. Epub 2012 Jul 26.

    PubMed 22840867
  • Jung JW, Lee BK, Park YH, Lee S, Jeong SJ, Lee SE, Jeong CW. Modified Seoul National University Renal Stone Complexity score for retrograde intrarenal surgery. Urolithiasis. 2014 Aug;42(4):335-40. doi: 10.1007/s00240-014-0650-7. Epub 2014 Mar 13.

    PubMed 24623504

Questions about this trial

What is this clinical trial studying?

An observational study of Flexible Ureteroscopy, run by Menoufia University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Islam Mohamed Abu-Bakr Mansour, M.B.B.Ch (201069121037, islam_mansour@med.menofia.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

stone free rate after flexible ureteroscopy (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05857501, which also lists 19 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in